The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 165.00
Bid: 160.00
Ask: 170.00
Change: 0.00 (0.00%)
Spread: 10.00 (6.25%)
Open: 165.00
High: 165.00
Low: 165.00
Prev. Close: 165.00
HUW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Reinsurance Agreement

26 Jul 2013 11:21

RNS Number : 2468K
Hampden Underwriting Plc
26 July 2013
 



26 July 2013

 

Hampden Underwriting PLC

("Hampden Underwriting" or the "Company")

 

Reinsurance releases capital for reinvestment in new opportunities

 

Hampden Underwriting, which provides investors with a limited liability direct investment into the Lloyd's insurance market, is pleased to announce the significant release of capital achieved by way of an annually renewable reinsurance arrangement.

 

Overview of the transaction

 

§ Collateralised quota share reinsurance agreement commencing with 2013 year of account

§ 50% of the Company's 2013 insurance exposure ceded to reinsurer

§ Release of £4.1m (approximately 50%) of the Company's £8.2m of Funds at Lloyd's) for reinvestment in new opportunities

§ Ratcheted, performance-based profit commission payable to the Company of between 10% and 20% of the profits arising on business ceded in each period

§ Minimum term of one year renewable annually thereafter

 

 

Commenting upon this transaction Sir Michael Oliver, the Company's Chairman, said:

"This transaction presents Hampden Underwriting with a welcome source of capital with which to fund near-term opportunities the Company wishes to pursue and does so on attractive commercial terms. The Board regularly considers the relative merits of alternative sources of capital and is confident that this is an appropriate funding option at this time."

 

Commenting upon this transaction Nigel Hanbury, the Company's Chief Executive, said:

 

"Current market conditions continue to present the Company with attractive investment opportunities which require funding. We are delighted to have been able to successfully conclude this transaction which provides the Company with a modest war chest with which we can continue to progress acquisition opportunities. The reinsurance terms provide a profit commission in good underwriting years and a reduced risk exposure in disappointing underwriting years in a spectrum that is both equitable and commercially attractive. Its annually renewable feature provides Hampden Underwriting with certainty for 2013 as well as the appropriate opportunity to review the arrangement from time to time."

 

 

 

For further information please contact:

Hampden Underwriting

 

Nigel Hanbury

nigel.hanbury@hampdenplc.com

Smith & Williamson Corporate Finance

 

David Jones

020 7131 4000

 

Additional information on the reinsurance arrangements

The Company has entered a reinsurance agreement with Hampden Insurance PCC (Guernsey) Limited - Cell 6 ("Cell 6"), a newly-formed special purpose vehicle. On a back-to-back basis, Cell 6 has reinsured the reinsurance risk with Bermudan reinsurer, XL Re Ltd ("XL"), part of global NYSE-quoted insurer XL Group plc.

 

The key terms of the arrangements are as follows:

- XL will take on via Cell 6 the risks and rewards of 50% of the Company's existing 2013 underwriting activities (although the activities themselves and the underwriting capacity will remain the Company's);

- XL will provide a letter of credit to Lloyd's in an amount of £4.1m (approximately 50% of the Company's existing funds at Lloyd's ("FAL"), enabling an equivalent amount to be released from FAL to the Company;

- XL will pay a profit commission of between 10% and 20% of profits from the business ceded to the Company (via Cell 6) depending on the results of the relevant insurance years of account;

- XL will pay a fee to Cell 6 of 1.5% per year of account of the value of the letter of credit provided to Lloyd's and Cell 6 will pay this on to the Company, less the Company's share of Cell 6's management fees, costs and expenses which is estimated to be approximately £12,500 per annum; and

- the reinsurance arrangements apply to the Company's 2013 year of account and are renewable annually thereafter.

 

Cell 6 is ultimately 51% owned by Nigel Hanbury (a director and 14.8% shareholder in the Company) and 49% by Hampden Capital plc (a 11.9% shareholder in the Company). Nigel Hanbury and a number of Lloyd's underwriting entities ultimately owned by him and his family have entered reinsurance agreements with Cell 6 on a pari passu basis. The terms of the transaction have been approved by the independent members of the Company's board of directors.

 

 

About Hampden Underwriting plc

Hampden Underwriting plc has been incorporated primarily to provide a limited liability direct investment into the Lloyd's insurance market. Hampden Underwriting plc is quoted on the London Stock Exchange's AIM market (ticker: HUW). For further information please visit www.hampdenplc.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUNARROBABUAR
Date   Source Headline
19th Dec 20229:07 amRNSGrant of LTIP Awards and Directors' Dealings
14th Dec 202212:47 pmRNSHolding(s) in Company
13th Dec 202211:29 amRNSResult of GM, TVR and Directors' Participation
12th Dec 20227:00 amRNSResult of Open Offer
24th Nov 202212:54 pmRNSReplacement - Result of Placing and Subscription
24th Nov 20227:00 amRNSResult of Placing and Subscription
23rd Nov 20224:45 pmRNSFundraising to raise up to approximately £13.5m
29th Sep 20227:00 amRNSHalf-year Report
22nd Aug 20227:00 amRNSQuarterly Syndicate Mid Point Forecasts
29th Jun 20221:13 pmRNSResult of AGM
1st Jun 20222:31 pmRNSPosting of Annual Report and Notice of AGM
27th May 20227:00 amRNSFinal Results
23rd May 20229:10 amRNSQuarterly Syndicate Mid Point Forecasts
8th Apr 20227:00 amRNSPCA Shareholding
1st Apr 20227:00 amRNSDirector/PDMR Shareholding
25th Mar 20227:00 amRNSSyndicate Mid Point Forecasts and Estimate of NAV
4th Mar 20227:00 amRNSDirector/PDMR Shareholding
25th Feb 20227:37 amEQSHelios Underwriting (HUW): Initiation - Increased Lloyd's participation at the right time
10th Jan 20228:56 amRNSAcquisition
4th Jan 20227:00 amRNSDirector/PDMR Shareholding
4th Jan 20227:00 amRNSTotal Voting Rights
22nd Dec 20217:01 amRNS2022 Helios Retained Capacity
22nd Dec 20217:00 amRNSAcquisition of further Limited Liability Vehicles
20th Dec 20217:00 amRNSAcquisition, Issue of Equity & Total Voting Rights
6th Dec 20217:00 amRNSDirector/PDMR Shareholding
2nd Dec 20217:00 amRNSAcquisition of further Limited Liability Vehicles
1st Dec 20212:31 pmRNSTotal Voting Rights
26th Nov 20217:00 amRNSQuarterly Syndicate Mid-point Forecasts
22nd Nov 20217:00 amRNSDirector/PDMR Shareholding
17th Nov 20217:00 amRNSAcquisition of Shareholding, Issue of Equity & TVR
15th Nov 202111:27 amRNSCapacity Value Update
15th Nov 20217:00 amRNSDirector/PDMR Shareholding
11th Nov 20217:00 amRNSAcquisition of further Limited Liability Vehicles
8th Nov 20217:00 amRNSDirector/PDMR Shareholding
18th Oct 20217:00 amRNSDirector/PDMR Shareholding
8th Oct 20217:00 amRNSAcquisition of further Limited Liability Vehicles
4th Oct 20217:00 amRNSAcquisition of Further Limited Liability Vehicles
30th Sep 20217:00 amRNSHalf-year Report
23rd Sep 20217:00 amRNSAcquisition of Limited Liability Vehicles
22nd Sep 20217:00 amRNSAcquisition, Issue of Equity & Total Voting Rights
20th Aug 20217:00 amRNSQuarterly Syndicate Mid-point Forecasts
17th Aug 20217:00 amRNSIssue of Equity and Director/PDMR Shareholding
28th Jul 20217:00 amRNSDirector/PCA Shareholding
29th Jun 20211:32 pmRNSResult of AGM
16th Jun 20217:00 amRNSUpdate re AGM
2nd Jun 20217:00 amRNSDirector/PCA Shareholding
1st Jun 20212:21 pmRNSDividend Declaration
28th May 20217:00 amRNSFinal Results for the year ended 31 December 2020
18th May 20212:30 pmEQSHardman & Co Investor Forum research: Helios Underwriting (HUW): Timing its growth with the insurance cycle
14th May 20217:00 amRNSQuarterly Syndicate Mid-point Forecasts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.